(PubMed) Byun E, Lim JW, Kim JM, Kim H
Nogueiras R, Prez-Tilve D, Veyrat-Durebex C, Morgan DA, Varela L, Haynes WG, et al

Landscapes Health & Medical Sciences (AREA) Life Sciences & Earth Sciences (AREA) Animal Behavior & Ethology (AREA) General Health & Medical Sciences (AREA) Public Health (AREA) Veterinary Medicine (AREA) Chemical & Material Sciences (AREA) Epidemiology (AREA) Medicinal Chemistry (AREA) Pharmacology & Pharmacy (AREA) Dermatology (AREA) Zoology (AREA) Gastroenterology & Hepatology (AREA) Endocrinology (AREA) Engineering & Computer Science (AREA) Bioinformatics & Cheminformatics (AREA) Immunology (AREA) Birds (AREA) Proteomics, Peptides & Aminoacids (AREA) Dispersion Chemistry (AREA) Cosmetics (AREA) Abstract Description HAUTKOSMETISCHE ZUSAMMENSETZUNG ENTHALTEND MELANOTAN II UND DEREN VERWENDUNG ALS HAUTBRAUNUNGSMITTEL SKIN-COSMETIC COMPOSITION CONTAINING MELANOTAN II AND THE USE THEREOF AS A SKIN-TANING AGENT Die vorliegende Erfindung betrifft eine topisch anwendbare hautkosmetische Zusammensetzung und deren Verwendung als Hautbrunungsmittel.The present invention relates to a topically applicable skin cosmetic composition and its use as a skin tanning agent

Its active ingredient, semaglutide, is part of a drug class called GLP-1 receptor agonists
While these associations are robust, interventional evidence remains preliminary, mainly from small-scale probiotic or dietary modification studies